Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Emotion and Symptom-Focused Engagement (EASE) for parents of children with cancer

Official title: Emotion and Symptom-Focused Engagement (EASE) for Caregivers: A Phase III Randomized Controlled Trial of an Intervention Targeting Traumatic Stress in Parents of Children With Cancer

Run by University Health Network, Toronto · NCT06367556 · Data updated 2026-11-12

This trial will test whether adding the EASE psychotherapy to usual care helps parents of children newly diagnosed or relapsed with cancer have fewer traumatic stress symptoms over six months.

More Pediatric Cancer trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment306 (estimated)
SponsorUniversity Health Network, Toronto
Academic / other
Locations2 sites (Toronto, Ontario and 1 other locations)
StatusRecruiting
StartedFebruary 14, 2025
Main results expectedOctober 1, 2027
Study endsOctober 1, 2028
Registry record updatedDecember 17, 2025
Trial IDNCT06367556 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are English-speaking primary family caregivers aged 18 or older of a child under 18 who was diagnosed or relapsed with a life-threatening cancer within the past six months and is receiving active cancer therapy.

Probably not a fit

Caregivers with major cognitive or communication impairments, active suicidal intent, those already in formal psychotherapy, or whose child is not expected to survive the study period are unlikely to be eligible or to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This Phase III randomized controlled trial compares EASE plus usual care to usual care alone in primary caregivers of children under 18 who have been newly diagnosed or relapsed with life-threatening cancer within the prior six months. Participants complete questionnaires at enrolment and at 4, 8, and 12 weeks and six months, with the primary outcome defined as traumatic stress symptom severity summarized by area under the curve over six months. The trial excludes caregivers with significant cognitive or communication impairment, active suicidal intent, current formal psychotherapy, or whose child is not expected to survive the study period. Optional qualitative interviews will capture caregiver experiences with the intervention.

Why it matters

Potential benefit: If successful, EASE could reduce traumatic stress symptoms in parents and improve their coping and day-to-day functioning while caring for a child with cancer.

How similar studies have gone: Related emotion-focused and symptom-targeted psychotherapies for caregivers have shown some positive results in prior studies, but EASE is a novel, tailored intervention being tested in a definitive Phase III trial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Self-identified primary family caregiver/guardian (i.e., parent assuming the majority of care activities) of a child: i) \<18yo; ii) diagnosed with a new or relapsed life-threatening cancer within the preceding six months (disease-type eligibility per the Pediatric Oncology Group of Ontario Networked Information System); and iii) receiving active cancer therapy;
* Age ≥18 years; and,
* Able to complete outcome measures and engage in EASE in English, which need not be their first language.

Exclusion Criteria:

* Impairment in cognitive functioning or communication that would preclude participation in EASE sessions or outcome measure completion, as determined by the research team;
* Receiving formal ongoing psychotherapy at the time of recruitment;
* Active suicidal intention, based on an item in the Distress Assessment and Response Tool (DART) that has been widely used in suicidal intention screening in cancer; or,
* Child not expected to survive past the duration of trial, as determined by the child's medical team.

Where it's running

  • The Hospital for Sick Children
    Toronto, Ontario, Canada
    Recruiting
  • Princess Margaret Cancer Centre - University Health Network
    Toronto, Ontario, Canada
    Active not recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.